Literature DB >> 9366521

Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells.

P B Dirks1, K Patel, S L Hubbard, C Ackerley, P A Hamel, J T Rutka.   

Abstract

We have characterized the expression and activity of the cell cycle regulatory machinery and the organization of the cytoskeleton of the p16(Ink4a)-deficient astrocytoma cell line, U343 MG-a (U343), following retinoic acid (RA) treatment. RA causes cell cycle arrest at low cell density and significant morphological changes in U343 cells, reflected by reorganization of the intermediate filament, GFAP, and actin. RA-induced cell cycle arrest is also associated with induction of p27Kip1 expression, inhibition of cdk2-associated kinase activity and alteration of the phosphorylation state of the pRB-family proteins. We next determined the effect of inducing expression of the cyclin dependent kinase inhibitors (CKI's), p16(Ink4a), p21Cip1/Waf1 or p27Kip1 on the proliferation and morphology of these malignant astrocytoma cells in the absence and presence of RA. Induction of p16, p21 or p27, using the tetracycline repressor system, potently inhibits proliferation of U343 cells. However, rather than resembling RA-treated cells, CKI-induced U343 cells become flat with abundant cytoplasm and perinuclear vacuolization. CKI-induced morphological alterations are accompanied by a significant reorganization of glial filaments within the cytoplasm. Interestingly, when U343 cells are growth arrested by p16, p21 or p27 induction and treated simultaneously with RA, a dramatic morphological change occurs, cells acquiring multiple long, tapering processes reminiscent of primary astrocytes. This rearrangement is accompanied by reorganization of GFAP, vimentin and actin. Vimentin specifically relocalizes to the tips of the long processes which form. The arrangement of intermediate filaments in these cells is, in fact, indistinguishable from their arrangement in primary human astrocytes. These data demonstrate that when a strong proliferative block, produced by CKI expression, occurs in conjunction with the morphogenic signals generated by RA, these p16-deficient malignant astrocytoma cells are induced to phenotypically resemble normal astrocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366521     DOI: 10.1038/sj.onc.1201392

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  Multi-agent cytostatic treatment of 'low-grade' gliomas.

Authors:  M E Linskey
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

2.  Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta1-stimulated rat hepatic stellate cells.

Authors:  Guang-Cun Huang; Jin-Sheng Zhang; Yue-E Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis.

Authors:  Hong-Xing Li; Wei Zhao; Yan Shi; Ya-Na Li; Lian-Shuang Zhang; Hong-Qin Zhang; Dong Wang
Journal:  Tumour Biol       Date:  2015-06-06

4.  Inhibition of γ-secretase by retinoic acid chalcone (RAC) induces G2/M arrest and triggers apoptosis in renal cell carcinoma.

Authors:  Qing-Chun Li; Hong-Jun Li; Shi Liu; Yun Liang; Xue Wang; Lei Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Treatment of recurrent malignant gliomas with 13-cis-retinoic acid naphthalene triazole.

Authors:  Pi-Feng Jia; Wei-Ting Gu; Wei-Feng Zhang; Feng Li
Journal:  Neurol Sci       Date:  2015-01-06       Impact factor: 3.307

6.  Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Authors:  Matthias Simon; Christian Simon; Gertraud Köster; Volkmar H J Hans; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

7.  Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.

Authors:  C Fels; C Schäfer; B Hüppe; H Bahn; V Heidecke; C M Kramm; C Lautenschläger; N G Rainov
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

Review 8.  Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.

Authors:  T G Mainprize; M D Taylor; J T Rutka; P B Dirks
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

9.  Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation.

Authors:  Adriana Oliva; Adriana Borriello; Stefania Zeppetelli; Angelo Di Feo; Pilade Cortellazzi; Vega Ventriglia; Maria Criscuolo; Vincenzo Zappia; Fulvio Della Ragione
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

10.  Analysis of mammalian septin expression in human malignant brain tumors.

Authors:  Dong-Seok Kim; Sherri-Lynn Hubbard; Aurelia Peraud; Bodour Salhia; Keiichi Sakai; James T Rutka
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.